This 12-month, open-label, nonrandomized prospective controlled trial evaluated the effectiveness and safety of a one-time injection of autologous bone marrow mesenchymal stem cells (BM-MSCs) targeted simultaneously into multiple spinal structures (discs, facets, spinal nerves, and sacroiliac joints) to address severe chronic low back pain from multi-structure lumbar degeneration.

This prospective, randomized, controlled trial compared the efficacy and safety of ultrasound-guided transforaminal injections of autologous platelet-rich plasma (PRP) versus steroids in 124 patients suffering from radicular pain due to lumbar disc herniation.

This triple-blinded randomized controlled trial evaluated the efficacy and safety of autologous platelet-rich plasma (PRP) versus a traditional corticosteroid (triamcinolone) via transforaminal epidural injection for single-level lumbar disc herniation.